Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND ABCG2, ABC15, ABCP, BCRP, BCRP1, BMDP, CD338, CDw338, EST157481, GOUT1, MRX, MXR, MXR-1, MXR1, UAQTL1 AND Prognosis
18 results:

  • 1.
    Sałagacka-Kubiak A; Zawada D; Saed L; Kordek R; Jeleń A; Balcerczak E
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445716
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Identification of Prognostic Factors in Cholangiocarcinoma Based on Integrated ceRNA Network Analysis.
    Jin H; Liu W; Xu W; Zhou L; Luo H; Xu C; Chen X; Chen W
    Comput Math Methods Med; 2022; 2022():7102736. PubMed ID: 36158120
    [TBL] [Abstract] [Full Text] [Related]  

  • 3.
    Bhattacharya A; Mukherjee S; Khan P; Banerjee S; Dutta A; Banerjee N; Sengupta D; Basak U; Chakraborty S; Dutta A; Chattopadhyay S; Jana K; Sarkar DK; Chatterjee S; Das T
    Sci Signal; 2020 Oct; 13(654):. PubMed ID: 33082288
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A comprehensive analysis of the microbiota composition and gene expression in colorectal cancer.
    Zhang Q; Zhao H; Wu D; Cao D; Ma W
    BMC Microbiol; 2020 Oct; 20(1):308. PubMed ID: 33050883
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Clinical Implications of cancer Stem Cell Markers and ABC Transporters as a Predictor of prognosis in colorectal cancer Patients.
    Kim BH; Oh HK; Kim DW; Kang SB; Choi Y; Shin E
    Anticancer Res; 2020 Aug; 40(8):4481-4489. PubMed ID: 32727778
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Irinotecan toxicity during treatment of metastatic colorectal cancer: focus on pharmacogenomics and personalized medicine.
    Paulík A; Nekvindová J; Filip S
    Tumori; 2020 Apr; 106(2):87-94. PubMed ID: 30514181
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Protective role of abcg2 against oxidative stress in colorectal cancer and its potential underlying mechanism.
    Nie S; Huang Y; Shi M; Qian X; Li H; Peng C; Kong B; Zou X; Shen S
    Oncol Rep; 2018 Oct; 40(4):2137-2146. PubMed ID: 30066914
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Implications of abcg2 Expression on Irinotecan Treatment of colorectal cancer Patients: A Review.
    Nielsen DL; Palshof JA; Brünner N; Stenvang J; Viuff BM
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28880238
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Expression of the cancer stem cell markers abcg2 and OCT-4 in right-sided colon cancer predicts recurrence and poor outcomes.
    Hu J; Li J; Yue X; Wang J; Liu J; Sun L; Kong D
    Oncotarget; 2017 Apr; 8(17):28463-28470. PubMed ID: 28212529
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Prognostic impact of membranous ATP-binding cassette Sub-family G member 2 expression in patients with colorectal carcinoma after surgical resection.
    Kang D; Park JM; Jung CK; Lee BI; Oh ST; Choi MG
    Cancer Biol Ther; 2015; 16(10):1438-44. PubMed ID: 26176272
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. CES2, abcg2, TS and Topo-I primary and synchronous metastasis expression and clinical outcome in metastatic colorectal cancer patients treated with first-line FOLFIRI regimen.
    Silvestris N; Simone G; Partipilo G; Scarpi E; Lorusso V; Brunetti AE; Maiello E; Paradiso A; Mangia A
    Int J Mol Sci; 2014 Sep; 15(9):15767-77. PubMed ID: 25198900
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Patients with CD133-negative colorectal liver metastasis have a poor prognosis after hepatectomy.
    Yamamoto S; Tanaka K; Takeda K; Akiyama H; Ichikawa Y; Nagashima Y; Endo I
    Ann Surg Oncol; 2014 Jun; 21(6):1853-61. PubMed ID: 24554065
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. cancer stem cell gene profile as predictor of relapse in high risk stage II and stage III, radically resected colon cancer patients.
    Giampieri R; Scartozzi M; Loretelli C; Piva F; Mandolesi A; Lezoche G; Del Prete M; Bittoni A; Faloppi L; Bianconi M; Cecchini L; Guerrieri M; Bearzi I; Cascinu S
    PLoS One; 2013; 8(9):e72843. PubMed ID: 24023782
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. MiR-142-3p functions as a tumor suppressor by targeting CD133, abcg2, and Lgr5 in colon cancer cells.
    Shen WW; Zeng Z; Zhu WX; Fu GH
    J Mol Med (Berl); 2013 Aug; 91(8):989-1000. PubMed ID: 23619912
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The role of microRNA in metastatic colorectal cancer and its significance in cancer prognosis and treatment.
    Tokarz P; Blasiak J
    Acta Biochim Pol; 2012; 59(4):467-74. PubMed ID: 23173124
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Inhibition of Wnt signaling pathway decreases chemotherapy-resistant side-population colon cancer cells.
    Chikazawa N; Tanaka H; Tasaka T; Nakamura M; Tanaka M; Onishi H; Katano M
    Anticancer Res; 2010 Jun; 30(6):2041-8. PubMed ID: 20651349
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Expression of drug pathway proteins is independent of tumour type.
    Zhang W; Shannon WD; Duncan J; Scheffer GL; Scheper RJ; McLeod HL
    J Pathol; 2006 Jun; 209(2):213-9. PubMed ID: 16508919
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The epidermal growth factor receptor tyrosine kinase inhibitor gefitinib sensitizes colon cancer cells to irinotecan.
    Braun AH; Stark K; Dirsch O; Hilger RA; Seeber S; Vanhoefer U
    Anticancer Drugs; 2005 Nov; 16(10):1099-108. PubMed ID: 16222152
    [TBL] [Abstract] [Full Text] [Related]  

    of 1.